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tent Malposition During Implantation for
ascular Obstruction in Patients With
ongenital and Acquired Heart Disease
effery Meadows, MD, David Teitel, MD, Phillip Moore, MD
an Francisco, California
bjectives We evaluated the anatomic and technical factors predicting stent malposition and em-
olization in patients undergoing endovascular stent implantation for relief of noncoronary vascular
bstruction.
ackground Endovascular stent implantation provides a highly effective, minimally invasive solution
o vascular obstruction in patients with structural heart disease. However, stent implantation is tech-
ically challenging and stent embolization occurs in up to 5.5% of cases.
ethods We reviewed patient and procedural characteristics of all endovascular stent implantations
erformed for relieving noncoronary vascular obstruction from January 1, 1999, through December
1, 2009. Univariate and multivariate predictors of stent malposition or embolization were explored
hrough logistic regression methods.
esults During the 10-year study period, 429 stents were implanted. Of these, 399 were placed for
elief of vascular obstruction in 267 patients during 322 procedures. Initial implantation failure oc-
urred in 33 patients (8.3%), including stent malposition in 18 (4.5%) and stent embolization in 15
3.8%). Patient size and vascular obstruction caused by external compression or a vascular fold were
ndependent predictors of stent malposition or embolization. All malpositioned and embolized
tents were successfully managed without surgery, and none resulted in death, sustained hemody-
amic instability, or important vascular injury.
onclusions Endovascular stent implantation is a highly effective and safe means of relieving non-
oronary vascular obstruction in patients with congenital and acquired structural heart disease.
tent embolization occurs in approximately 3.8% of implantation procedures but can be managed
uccessfully without surgical intervention. Anatomic and technical factors predict stent malposition,
nd consideration of these factors may improve procedural results. (J Am Coll Cardiol Intv 2010;3:
080–6) © 2010 by the American College of Cardiology Foundation
rom the Division of Pediatric Cardiology, University of California, San Francisco, San Francisco, California. The authors have
eported that they have relationships to disclose.anuscript received June 24, 2010, accepted July 12, 2010.
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1081ndovascular stent implantation has become a common
eans of relieving noncoronary vascular obstruction in
hildren and adults with structural heart disease. The
mmediate hemodynamic effects of stent implantation are
ell documented (1–9). However, endovascular stent im-
lantation is technically challenging and stent embolization
omplicates up to 5.5% of such procedures (1,2,5,6,10,11).
he determinants of successful endovascular stent implan-
ation, and the consequences of stent malposition are poorly
tudied. We sought to: 1) determine the technical and
natomic factors predicting stent malposition; and 2) de-
cribe the consequences of stent malposition and emboliza-
ion in this patient population.
See page 1087
ethods
atients were identified from the University of California,
an Francisco Pediatric Cardiac Catheterization Laboratory
atabase through a computerized search for all procedures
nvolving the placement of a balloon-expandable endovas-
ular stent during the period of January 1, 1999, through
ecember 31, 2009. Self-expanding and intraoperative
tent placements were not included. All cardiac catheteriza-
ion reports and angiographic images were reviewed. Data
n predictor variables were abstracted by the primary inves-
igator prior to ascertainment of the outcome. Patients were
xcluded from analysis if stent placement was not for the
urpose of vascular obstruction (e.g., patent ductus arterio-
us, atrial or ventricular septal stenting). Right ventricle–to–
ulmonary artery conduits and aortopulmonary shunts were
ncluded.
eﬁnition of outcome variables. The outcome of stent
lacement was recorded as a pre-specified ordinal variable as
erfect, adequate, malposition, or embolized. Both perfect
nd adequate stent placement were considered implantation
uccess and required successful placement of the stent across
he area of vascular obstruction with greater than 50%
ecrease in measured pressure gradient and/or final expan-
ion of the stenotic lesion to at least 75% of the diameter of
he balloon used to implant the stent. Perfect and adequate
tent placement differed qualitatively based upon final po-
itioning relative to the surrounding anatomic structures to
ccount for complex anatomic settings, such as bifurcation
esions. For example, precise “centering” of the stent upon
he lesion was not considered criteria for a perfect implan-
ation if the anatomy suggested that alternative position was
ecessary to achieve an optimal anatomic or hemodynamic
esult. Similarly, avoidable jailing of a side branch vessel
uring an otherwise perfect implantation resulted in classi-
cation as adequate rather than perfect. Classification as an
mplantation failure included both stent malposition and
tent embolization. Categorization as stent malposition re- iuired stable placement of the stent in the area of vascular
bstruction but with an inadequate hemodynamic or angio-
raphic result such that additional stent placement or
ntervention was required. Simple redilation of a successfully
laced stent and intentional placement of multiple stents
ere not considered criteria for stent malposition. A stent
as considered embolized if it was not adherent to the
ascular wall and was mobile in the circulation at any point
fter balloon inflation. In an effort to provide the most
linically useful analysis based upon the need for further
ntervention, final analysis was based upon dichotomous
lassification of the outcome variable as implantation suc-
ess (perfect and adequate) or implantation failure (malpo-
ition and embolization).
eﬁnitions of predictor variables. Balloon-stenosis ratio was
efined as the unitless ratio of delivery balloon diameter to
he minimal lumen diameter of the vascular obstruction.
alloon-stent ratio was defined as the unitless ratio of the
alloon length to unexpanded stent length. Pre-dilation was
efined as full inflation of an angioplasty balloon across the
ascular lesion prior to implantation of the stent. Partial
nflation of an angioplasty balloon across the lesion was not
onsidered pre-dilation. Vascular lesions were classified into
of 4 categories based upon the angiographic appearance
rior to intervention (Fig. 1).
iscrete obstruction was defined
s focal narrowing of the vascu-
ar lumen (Fig. 1A). Diffuse ob-
truction was defined as a long-
egment narrowing or hypoplasia
f the vascular lumen without external compression (Fig.
B). Vascular folds and external compression were defined
y the relationship of the obstructed vessel with itself or
urrounding structures, respectively (Fig. 1C). For analysis,
hese last 2 lesions were considered together as highly
ompliant lesions. The final category of vascular lesion was
ny type of vascular obstruction already containing an
ndovascular stent (Fig. 1D). This category was created to
eflect the combined effects of a relatively predictable
oncompliant “landing zone” and continuous visual land-
ark during stent implantation.
ata analysis. Data were collected into a standard spread-
heet (Microsoft Excel, Microsoft, Redmond, Washington)
nd exported to STATA version 11 (StataCorp, College
tation, Texas) for statistical analysis. Normally distributed
ontinuous variables were summarized as means and stan-
ard deviations. Non-normally distributed variables were
ummarized as medians and ranges. Comparison of pre-
nd post-procedural paired data was performed using the
aired samples t test or Wilcoxon signed ranks test, as
ppropriate to their distributions. Evaluation of unadjusted
isk factors for stent implantation failure was performed
sing logistic regression with clustering on patient study
Abbreviations
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CI  confidence interval
OR  odds ratiodentification number. Adjusted analysis of risk factors for
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1082tent implantation failure was performed using multiple
ariable logistic regression with clustering on patient study
dentification number. Final model selection was performed
sing backward selection with maximization of the area
nder the receiver-operator characteristic curve and mini-
ization of the Akaike and Bayesian information criteria.
tandard model checking was performed.
esults
atient, anatomic, and procedural characteristics. During
he 10-year study period, 429 stents were implanted. Of
hese, 399 were placed for relief of vascular obstruction in
67 patients during 322 procedures (Table 1). The remain-
ng 30 stents were placed for reasons other than vascular
bstruction. Seventy-six subjects had more than 1 stent
mplanted (range 2 to 6). The total number of stents
Figure 1. Classification of Vascular Obstruction
(A) Discrete obstruction in a patient with coarctation of the aorta. (B) Hypoplas
excluded by additional angiography). (C) Compression of the left pulmonary ar
connection (note contrast translucency at area of compression (arrow), an ove
obstruction at site of fractured existing stent in left pulmonary artery.mplanted per year varied moderately, ranging from 31 to q5; however, most variation was explained by case volume as
he proportion of cases involving stent implantation re-
ained fairly constant (6.9% to 8.5%). Most stents were
laced in either the aorta or pulmonary arteries.
The median patient age at the time of stent implantation
as 9 years (ranging from 2 days to 59 years). Endovascular
tent placement in infants and smaller children occurred
ost frequently in the setting of emergent perioperative
emodynamic instability, in non-native sources of pulmo-
ary blood flow (shunts or conduits), or as palliative inter-
entions in patients deemed unsuitable for surgery.
Endovascular stent placement resulted in significant re-
uctions in measured pressure gradients (Table 2). In
ulsatile circulations, the median percent reduction in peak
ystolic pressure gradients was 85% (10% to 100%). Ten
rocedures had residual peak gradients 20 mm Hg, of
hich 3 were intentionally staged interventions with subse-
the left pulmonary artery in a patient after Fontan (compression was
y the ascending thoracic aorta in a patient after superior cavopulmonary
aortic position was demonstrated in a separate angiogram). (D) Vascularia of
tery b
rlyinguent hemodynamic success upon reintervention.
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1083tent malposition and embolization. Stent malposition or
mbolization occurred in 33 (8%) of 399 stent implantations
Table 3). Fifteen stents (3.8%) embolized during implanta-
ion in 13 patients. The 18 remaining malpositioned stents
ere stable within the intended vascular structure but failed
o yield either acceptable anatomic or hemodynamic results.
n all of these cases, additional stent placement resulted in
rocedural success. There were 16 pairs of bifurcating or
kissing” stents. None resulted in malposition or emboliza-
ion. Balloon rupture during stent implantation occurred in
6 cases but directly contributed to stent malposition in only
Table 2. Median (Range) of Initial and Final Pressure Gradients
Site Initial Gradient Final Gradient p Value
Pulsatile circulations 25 (3–120) 5 (1–56) 0.0001
Aorta 25 (4–85) 1 (1–45) 0.0001
Pulmonary artery 22 (3–120) 7.5 (1–41) 0.0001
Table 1. Patient and Vascular Characteristics
Stents 399
Patients 267
Procedures 322
Median patient age, yrs 9 2 days–58 years
Median body surface area, m2 1.14 0.16–2.37
Patient diagnosis
Tetralogy of Fallot 110
Isolated coarctation 104
Single ventricle 71
Other 101
Type of stent
Bare metal 370 93%
Pre-mounted 136 34%
Drug eluting 14 3.5%
Covered 10 2.5%
Site of stent placement
Aorta 131 33%
Pulmonary artery 200 50%
Main pulmonary artery 3
Proximal left pulmonary artery 108
Proximal right pulmonary artery 56
Branch left pulmonary artery 12
Branch right pulmonary artery 20
Systemic/pulmonary vein 27 7%
Superior vena cava 12
Inferior vena cava 2
Pulmonary vein 11
Other systemic vein 2
Right ventricular outﬂow tract or RV-PA conduit 21 5%
Fontan conduit/pathway 9 2%
Aortopulmonary shunt 8 2%
Aortopulmonary collateral 3 1%
RV-PA right ventricular-pulmonary artery.Nonpulsatile circulations 6.9 (1–21) 2.4 (1–3.9) 0.0001(embolization in 2). The odds ratio (OR) for stent
alposition with balloon rupture during implantation was
.7 (95% confidence interval [CI]: 1.20 to 11.62). Stent
alposition that occurred as a result of balloon rupture was
xcluded from further risk factor analysis.
Univariate predictors of stent malposition or emboliza-
ion included pre-dilation of the vascular obstruction (OR:
.5, 95% CI: 1.13 to 5.53) and obstruction due to vascular
old or external compression (OR: 20.6, 95% CI: 6.78 to
2.40) (Table 4). There was no influence of date of
mplantation upon risk for malposition or embolization.
ndependent predictors of stent malposition or embolization
ncluded body surface area (OR: 2.5, 95% CI: 1.15 to 5.42)
nd vascular obstruction due to fold or external compression
OR: 20.2, 95% CI: 5.64 to 72.03) (Table 5). After
djustment, the odds ratio associated with pre-dilation
emained relatively consistent, at 2.37, with borderline
tatistical significance, p  0.07.
utcome of embolized stents. Of the 15 stents that became
nstable in circulation, 2 were repositioned and secured
ithin the intended location with a larger balloon, 5 were
epositioned in the intended location and secured with the
lacement of an additional stent, and 7 were placed in an
nintended vascular structures (contralateral pulmonary ar-
ery in 3, descending thoracic aorta in 3, and iliac artery in
). One stent was compressed with the use of multiple
nares and removed from the body through a long sheath.
Table 3. Outcome of Stent Placement
Implantation success 366 91.7%
Perfect 205 51.4%
Adequate 161 40.3%
Implantation failure 33 8.3%
Malposition 18 4.5%
Embolization 15 3.8%
Table 4. Unadjusted Risk Factors for Stent Malposition and Embolization
OR p Value 95% CI
Age, yrs 0.99 0.87 0.97–1.03
Body surface area, m2 1.02 0.89 0.78–1.30
Pre-dilation 2.51 0.02 1.13–5.53
Pre-mounted stent 1.19 0.67 0.53–2.67
Stent length, mm 0.99 0.51 0.95–1.03
Balloon-stent ratio 1.76 0.20 0.73–4.22
Stenosis-balloon ratio 0.97 0.62 0.86–1.09
Pulsatile circulation 1.85 0.30 0.58–5.90
Type of vascular obstruction
Discrete Ref
Hypoplastic 1.01 0.89 0.41–2.82
Fold/compression 20.60 0.001 6.78–62.40
Existing stent 0.46 0.29 0.11–1.90CI confidence interval; OR odds ratio; Ref reference.
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1084tent embolization did not result in death, sustained hemo-
ynamic instability, or serious vascular injury in any case
upper limit of 95% CI: 22%).
omplications. Median procedure time, fluoroscopy time,
nd contrast use were higher in cases involving stent
alposition or embolization (Table 6); however, only the
ifference in fluoroscopy time was statistically significant.
omplications other than stent malposition or embolization
ccurred in 47 of 322 procedures (Table 7). The majority of
omplications were minor. Eleven major complications
ccurred, including 1 death from an uncontained aortic tear.
o major complication occurred as a result of stent malpo-
ition or embolization.
iscussion
oncoronary vascular obstruction occurs commonly in
any forms of congenital and acquired structural heart
isease and is an important cause of morbidity and mortal-
ty. Conventional therapeutic interventions in this situation
re surgery, balloon angioplasty, or endovascular stent im-
lantation. Among the available options, endovascular stent
mplantation provides a highly effective, minimally invasive
olution to vascular obstruction, with relatively low risk,
rocedural cost, and hospital lengths of stay (1,2,6,12–15).
ecause of concern for long-term vascular growth, stent
mplantation has been traditionally reserved for adults and
arger children. However, with the recognition that stents
an be further expanded and even broken through additional
ilation to keep up with somatic growth (16,17), the
opulation of patients undergoing stent placement has
Table 5. Independent Risk Factors for Stent Malposition
and Embolization
OR p Value 95% CI
Body surface area, m2 2.50 0.02 1.15–5.42
Pre-dilation 2.37 0.07 0.94–5.97
Stent length, mm 0.95 0.12 0.89–1.01
Stenosis-balloon ratio 0.97 0.75 0.79–1.19
Type of vascular obstruction
Discrete Ref
Hypoplastic 1.37 0.60 0.42–4.53
Fold/compression 20.20 0.001 5.64–72.03
Existing stent 0.33 0.32 0.04–2.85
Abbreviations as in Table 4.
Table 6. Median (Range) of Procedure Time, Fluoroscopy Time, and
Contrast Use
Implantation Failure Implantation Success p Value
Procedure time, min 334.6 (160–600) 303.4 (95–735) 0.13
Fluoroscopy time, min 67.3 (21.9–147.5) 52.8 (7.3–183) 0.04pContrast, cc/kg 2.4 (0.8–8.7) 2.3 (0.8–8.7) 0.14xpanded. However, stent implantation remains technically
hallenging. Despite refinements in equipment and tech-
ique, stent embolization occurs in 1.2% to 5.5% of stent
mplantation procedures, and approximately one-half of
hese appear to require surgical intervention (1,2,5,6,10,11).
nformation regarding stent malposition without frank em-
olization is absent from the literature and may be under-
eported because subsequent stent placement frequently
esults in a hemodynamically and technically successful
rocedure.
This study was undertaken with the conceptual frame-
ork that the determinants of successful endovascular stent
lacement may be broadly classified under 3 categories. The
rst encompasses characteristics of the patient and vascular
esion; including patient size, the type of vascular obstruc-
ion, and the size and type of the obstructed vessel. The
econd encompasses equipment and technical factors, such as
tent size or type, or factors that arise as a result of the interface
f these with the vascular lesion, such as the relation of the
tent or balloon to the vascular segment. The final category is
perator proficiency.
atient and vascular determinants. We examined the roles
f patient and vessel size and type of vascular obstruction
pon stent placement and found the type of vascular
bstruction to be the strongest predictor of stent implanta-
ion failure. Relative to discrete vascular obstructions, vas-
ular obstruction due to vascular fold or external compres-
ion was associated with a 20-fold increase in the odds of
tent malposition or embolization. These are relatively
ncommon causes of vascular obstruction, comprising only
% of this series, but may be underappreciated. External
ompression may be missed if not specifically considered
nd investigated, and the angiographic appearance of vas-
ular folds may be mistaken for discrete stenosis if not
arefully examined. Unfortunately, the associated risk of
hese lesions for stent implantation failure may be difficult to
anage because it is precisely these types of vascular
bstruction that are unlikely to respond to balloon angio-
Table 7. Procedural Complications
Procedures 313
Complications 47 15%
Major complications 11 3.5%
Aneurysm 4
Uncontrolled tear 1
Renal artery thrombosis 1
Bronchial compression 1
Stroke 2
Hemoptysis 2
Minor complications 37 11.8%
Balloon rupture 16
Jailed vessel 17
Other 10lasty without stent implantation. Pre-dilation of a lesion
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1085ay provide insight into its compliance and thereby help
istinguish discrete obstruction from vascular folds, but
re-dilation may carry independent risks. It seems reason-
ble that the use of larger implantation balloon diameters
ight mitigate this risk by providing better radial force
gainst these highly compliant vascular lesions but we are
nable to support this hypothesis with the available data.
We also found an association between larger patient size
nd the risk for failure. Interventional procedures in small
hildren are often considered technically more challenging.
ith respect to stent implantation, however, the greater
ascular space of larger patients may permit more room for
ndesired balloon movement during stent implantation. We
ound no association between stent malposition or emboli-
ation and patient age or implantation in a pulsatile circu-
ation when controlled for other factors.
quipment and technical determinants. We also examined
he roles of several technical factors upon stent placement,
ncluding the use of pre-mounted stents, pre-dilation of the
ascular lesion, stent length, the ratio of stent length to
alloon length, and the ratio of delivery balloon diameter to
inimal lumen diameter. Among these, only pre-dilation of
he vascular lesion was associated with an increased odds of
mprecise stent placement, although with only borderline
tatistical significance. The relationship is plausible because
re-dilation may reduce the effective vascular scaffold upon
hich the stent must be secured. However, caution should
e exercised in consideration of this finding: not only
ecause of the borderline test statistic, but also because
esidual confounding may exist. Specifically, the indications
or pre-dilation were neither standardized nor routinely
ecorded. It is likely that pre-dilation was performed more
ommonly in technically challenging lesions in order to
ssess balloon stability prior to stent implantation. This
nstitutional bias as well as other important considerations,
uch as partial pre-dilation, are not accounted for in our
odel and may confound the association between pre-
ilation and subsequent stent placement.
he consequences of stent malposition and embolization. All
rocedures with poorly positioned but stable (malposi-
ioned) stents were ultimately successful with additional
ntervention during the same procedure. No stent emboli-
ation in this series required surgical intervention and all
rocedures involving stent embolization were ultimately
uccessful during the same procedure after additional
ntervention.
tudy limitations. We were unable to assess the important
ffect of the primary interventionalist upon stent implanta-
ion for several reasons. First, at this institution, complex
nterventional cases are often performed with the assistance
f more than 1 attending interventionalist. As a result,
ecause of the retrospective nature of this study, we were
nable to identify and analyze the roles of specific individ-
als. In addition, the majority of stent implantations overhe study period were performed by a single intervention-
list, to whom a clear case complexity bias existed that was
ifficult to quantify. Finally, despite consideration of mul-
iple variables in this analysis residual confounding by
nrecognized factors must remain a consideration.
onclusions
ndovascular stent implantation is highly effective and a
afe means of relieving noncoronary vascular obstruction in
atients with congenital and acquired structural heart dis-
ase. Stent embolization occurs in approximately 3.8% of
tent implantation procedures but may be managed success-
ully without surgical intervention. Anatomic and technical
actors predict stent malposition and consideration of these
actors may improve procedural results.
eprint requests and correspondence: Dr. Jeffery Meadows,
ivision of Pediatric Cardiology, 505 Parnassus Avenue, Box
632, San Francisco, California 94143-4144. E-mail: jeffery.
eadows@ucsf.edu.
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